Medical University of South Carolina Hollings Cancer Center is a clinical research site located in Charleston, South Carolina, United States 29425.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Medical University of South Carolina Hollings Cancer Center has participated in 17 clinical trials with 6 currently active.
Therapeutic areas: Metastatic Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Prostate Cancer.
Sponsors: Medical University of South Carolina, Puma Biotechnology, Inc., University of Chicago.
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Medical University of South Carolina Hollings Cancer Center has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Medical University of South Carolina Hollings Cancer Center has 17 clinical trials on record, with 6 currently active. Their work covers Metastatic Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Prostate Cancer.
Yes — Medical University of South Carolina Hollings Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.